Abstract:Objective To investigate the effects of knocking down AKT1 and COX-2 by RNAi on the proliferation activity of U251 glioma cells in vitro.Methods The recombinant adenovirus vector which contained RNAi expression construct of AKT1 and COX-2 (rAd-A + C) was transfected into U251 cells.The silencing effects of RNAi on AKT1 and COX-2 expression were identified by realtime PCR and Western blot.Western blot was also undertaken to analyze the expression of some functional proteins.The proliferation activity of U251 cells transfected by rAd-A + C was evaluated by MTT and flow cytometry.Result RAd-A + C dramatically down-regulated the expression of AKT1 and COX-2 in U251 cells.As compared with parental and rAd-HK transfected cells,the protein expression of PCNA and CyclinDl was down-regulated in rAd-A + C treated cells,meanwhile p53 was upregulated.Decreased AKT1 and COX-2 expression in rAd-A + C transfected cells was accompanied by 7.0% to 7.8% decrease in U251 cells in S phase with G0/G1 phase arrest.Meanwhile,the proliferation activity was significantly decreased in rAd-A + C transfected cells by the MTT assay.Conclusion RNAi targeting AKT1 and COX-2 could significantly down-regulate their expression in a sequence-specific manner,exerting proliferation inhibition effect on U251 cells in vitro.Consequently,the recombinant adenovirus vector mediated RNAi gene therapy may be a new strategy in targeting molecular therapy of gliomas.

Suppressing Effects of Shrna Targeting AKT1 and COX-2 on Proliferation of Glioma Cell U251 in Vitro